Presenter: Alena Guggenheim, ND

Original Date: June 9, 2018

Ehlers-Danlos and generalized joint hypermobility syndromes are common genetic connective tissues disorders that can present in a heterogenous pattern. This talk will discuss the subtypes of EDS, common comorbidities, red flag symptoms that indicate possible CNS involvement and a treatment approach to improving outcomes. We will also over a common co-morbidity, postural orthostatic tachycardia syndrome that can impact gastrointestinal motility and predispose patients to developing small intestinal bacterial overgrowth. We will discuss lifestyle and pharmaceutical approaches to treatment for POTS. The following medications will be discussed: Florinef, midodrine, beta-blockers, IV saline, low dose naltrexone, mestinon, and Corlanor.

0.5 Pharmacology, 0.5 General (Total 1.0 CEUs) approved by OBNM